Hiroaki Ogata, MD1; Masafumi Fukagawa, MD2; Hideki Hirakata, MD3; Tatsuo Kagimura, PhD4; Masanori Fukushima, MD4; Tadao Akizawa, MD5; for the LANDMARK Investigators and Committees
doi : 10.1001/jama.2021.4807
JAMA. 2021;325(19):1946-1954
Among patients with hyperphosphatemia undergoing dialysis, it is unclear whether non–calcium-based phosphate binders are more effective than calcium-based binders for reducing cardiovascular events.
Elizabeth L. Whitlock, MD, MSc1; L. Grisell Diaz-Ramirez, MS2; Alexander K. Smith, MD, MPH2,3; W. John Boscardin, PhD2,4; Kenneth E. Covinsky, MD2; Michael S. Avidan, MB, BCh5; M. Maria Glymour, ScD, MS4
doi : 10.1001/jama.2021.5150
JAMA. 2021;325(19):1955-1964
It is uncertain whether coronary artery bypass grafting (CABG) is associated with cognitive decline in older adults compared with a nonsurgical method of coronary revascularization (percutaneous coronary intervention [PCI]).
Sivan Haia Perl, MD1; Atara Uzan-Yulzari, MSc2; Hodaya Klainer, BSc2; Liron Asiskovich, MSc2; Michal Youngster, MD3; Ehud Rinott, BSc4; Ilan Youngster, MD, MMSc5
doi : 10.1001/jama.2021.5782
JAMA. 2021;325(19):2013-2014
Sebastian Havervall, MD1; Axel Rosell, MD1; Mia Phillipson, PhD2; Sara M. Mangsbo, PhD2; Peter Nilsson, PhD3; Sophia Hober, PhD3; Charlotte Th?lin, MD, PhD1
doi : 10.1001/jama.2021.5612
JAMA. 2021;325(19):2015-2016
Daniel Saddawi-Konefka, MD, MBA1; Ariel Brown, PhD2; Isabella Eisenhart, BS2; Katharine Hicks, BA2; Eileen Barrett, MD, MPH3; Jessica A. Gold, MD, MS4
doi : 10.1001/jama.2021.2275
JAMA. 2021;325(19):2017-2018
US Preventive Services Task Force
doi : 10.1001/jama.2021.6238
JAMA. 2021;325(19):1965-1977
Colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52?980 persons in the US projected to die of colorectal cancer in 2021. Colorectal cancer is most frequently diagnosed among persons aged 65 to 74 years. It is estimated that 10.5% of new colorectal cancer cases occur in persons younger than 50 years. Incidence of colorectal cancer (specifically adenocarcinoma) in adults aged 40 to 49 years has increased by almost 15% from 2000-2002 to 2014-2016. In 2016, 26% of eligible adults in the US had never been screened for colorectal cancer and in 2018, 31% were not up to date with screening.
Jennifer S. Lin, MD1; Leslie A. Perdue, MPH1; Nora B. Henrikson, PhD1; Sarah I. Bean, MPH1; Paula R. Blasi, MPH1
doi : 10.1001/jama.2021.4417
JAMA. 2021;325(19):1978-1997
Colorectal cancer (CRC) remains a significant cause of morbidity and mortality in the US.
Amy B. Knudsen, PhD1,2; Carolyn M. Rutter, PhD3; Elisabeth F. P. Peterse, PhD4,5; Anna P. Lietz, BA1,6; Claudia L. Seguin, BA1; Reinier G. S. Meester, PhD4; Leslie A. Perdue, MPH7; Jennifer S. Lin, MD7; Rebecca L. Siegel, MPH8; V. Paul Doria-Rose, DVM, PhD9; Eric J. Feuer, PhD9; Ann G. Zauber, PhD10; Karen M. Kuntz, ScD11; Iris Lansdorp-Vogelaar, PhD4
doi : 10.1001/jama.2021.5746
JAMA. 2021;325(19):1998-2011
The US Preventive Services Task Force (USPSTF) is updating its 2016 colorectal cancer screening recommendations.
Lawrence O. Gostin, JD1; I. Glenn Cohen, JD2; Jana Shaw, MD, MPH3
doi : 10.1001/jama.2021.5283
JAMA. 2021;325(19):1933-1934
Mary M. McDermott, MD1,2; Anne B. Newman, MD, MPH3
doi : 10.1001/jama.2021.4609
JAMA. 2021;325(19):1935-1936
Srinivas Murthy, MD, CM, MHSc1; Patricia Fontela, MD2; Scott Berry, PhD3
doi : 10.1001/jama.2020.25007
JAMA. 2021;325(19):1937-1938
Adam S. Cifu, MD1
doi : 10.1001/jama.2021.6691
JAMA. 2021;325(19):1939-1940
Rebecca F. Gottesman, MD, PhD1; Michelle C. Johansen, MD, PhD1
doi : 10.1001/jama.2021.5816
JAMA. 2021;325(19):1941-1942
Kimmie Ng, MD, MPH1; Folasade P. May, MD, PhD, MPhil2; Deborah Schrag, MD, MPH1
doi : 10.1001/jama.2021.4133
JAMA. 2021;325(19):1943-1945
Rita Rubin, MA
doi : 10.1001/jama.2021.5333
JAMA. 2021;325(19):1926-1928
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2021.5601
JAMA. 2021;325(19):1929-1930
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2021.7164
JAMA. 2021;325(19):1932
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2021.6754
JAMA. 2021;325(19):1932
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2021.7165
JAMA. 2021;325(19):1932
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.6448
JAMA. 2021;325(19):1931
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.7215
JAMA. 2021;325(19):1931
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.7216
JAMA. 2021;325(19):1931
Jeneva Stone, PhD1
doi : 10.1001/jama.2021.4776
JAMA. 2021;325(19):2021
Jill Jin, MD, MPH1
doi : 10.1001/jama.2021.6557
JAMA. 2021;325(19):2026
Anna C. van der Burgh, BSc1; Ewout J. Hoorn, MD, PhD1; Layal Chaker, MD, PhD2
doi : 10.1001/jama.2021.3458
JAMA. 2021;325(19):2018
James A. Diao, BS1; Neil R. Powe, MD, MPH, MBA2; Arjun K. Manrai, PhD1
doi : 10.1001/jama.2021.3461
JAMA. 2021;325(19):2018-2019
Hui Mai, MD, PhD1; Tao Chen, PhD2; Bin Zhao, MD1
doi : 10.1001/jama.2021.4034
JAMA. 2021;325(19):2019-2020
Kazumi Kimura, MD, PhD1; Toshiaki Otsuka, MD, PhD2; Kentaro Suzuki, MD, PhD1
doi : 10.1001/jama.2021.4037
JAMA. 2021;325(19):2020
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟